Arcturus Therapeutics ARCT 深 沪
等待开盘 03-26 09:30:00 美东时间
7.135
+0.485
+7.29%
华盛通- 最 高7.17
- 今 开6.81
- 成交量 36.14万股
- 最 低 6.80
- 昨 收 6.65
- 总市值 2.03亿
- 52周最高 24.17
- 市盈率 静 --
- 换手率 1.27%
- 52周最低 5.85
- 委 比 2.31%
- 总股本 2842.31万
- 历史最高 129.71
- 量 比 0.84
- 振 幅 5.56%
- 历史最低 4.11
- 每 手 1
- 风险率 4.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
B. Riley Securities Initiates Coverage On Arcturus Therapeutics with Buy Rating, Announces Price Target of $22
B. Riley Securities analyst Mayank Mamtani initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and announces Price Target of $22.
03-18 18:45
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
Piper Sandler Maintains Overweight on Arcturus Therapeutics, Lowers Price Target to $25
Piper Sandler analyst Yasmeen Rahimi maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Overweight and lowers the price target from $72 to $25.
03-04 21:47
U.S. RESEARCH ROUNDUP-Crowdstrike, Oracle, Vulcan Materials
U.S. RESEARCH ROUNDUP-Crowdstrike, Oracle, Vulcan Materials March 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Crowdstrike, Oracle and Vulcan Materials, on Wednesday. HIGHLIGHTS * Crowdstrike CRWD.O : Bernstein rais
03-04 17:14
Arcturus Therapeutics Q4 Earnings Assessment
Arcturus Therapeutics (NASDAQ:ARCT) announced its Q4 earnings on Tuesday, March...
03-04 05:02
Earnings Scheduled For March 3, 2026
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is expected to rep...
03-03 19:11
Earnings Preview: Arcturus Therapeutics
Arcturus Therapeutics (NASDAQ:ARCT) is gearing up to announce its quarterly ear...
03-03 01:02
Arcturus Therapeutics Holdings Inc. published an update to their financial calendar
Arcturus Therapeutics Holdings Inc. published an update to their financial calendar Arcturus Therapeutics Holdings Inc. will release its fourth quarter and fiscal year 2025 financial results after the market close on Tuesday, March 3, 2026. The company will also host an earnings conference call and
02-18 05:01
